Taiwan · Delayed Price · Currency is TWD Sinphar Pharmaceutical Statistics
Total Valuation
TPE:1734 has a market cap or net worth of TWD 5.88 billion. The enterprise value is 6.81 billion.
| Market Cap | 5.88B |
| Enterprise Value | 6.81B |
Important Dates
The next estimated earnings date is Friday, March 20, 2026.
| Earnings Date | Mar 20, 2026 |
| Ex-Dividend Date | Jul 11, 2025 |
Share Statistics
TPE:1734 has 190.20 million shares outstanding. The number of shares has increased by 0.07% in one year.
| Current Share Class | 190.20M |
| Shares Outstanding | 190.20M |
| Shares Change (YoY) | +0.07% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 9.86% |
| Owned by Institutions (%) | 3.05% |
| Float | 137.44M |
Valuation Ratios
The trailing PE ratio is 17.07.
| PE Ratio | 17.07 |
| Forward PE | n/a |
| PS Ratio | 1.76 |
| PB Ratio | 1.64 |
| P/TBV Ratio | 1.81 |
| P/FCF Ratio | 14.70 |
| P/OCF Ratio | 10.27 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.42, with an EV/FCF ratio of 17.04.
| EV / Earnings | 19.71 |
| EV / Sales | 2.04 |
| EV / EBITDA | 10.42 |
| EV / EBIT | 16.57 |
| EV / FCF | 17.04 |
Financial Position
The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.47.
| Current Ratio | 2.21 |
| Quick Ratio | 1.51 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | 2.56 |
| Debt / FCF | 4.18 |
| Interest Coverage | 11.55 |
Financial Efficiency
Return on equity (ROE) is 9.50% and return on invested capital (ROIC) is 8.25%.
| Return on Equity (ROE) | 9.50% |
| Return on Assets (ROA) | 4.15% |
| Return on Invested Capital (ROIC) | 8.25% |
| Return on Capital Employed (ROCE) | 8.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.40 |
Taxes
In the past 12 months, TPE:1734 has paid 64.75 million in taxes.
| Income Tax | 64.75M |
| Effective Tax Rate | 16.22% |
Stock Price Statistics
The stock price has increased by +5.17% in the last 52 weeks. The beta is 0.13, so TPE:1734's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | +5.17% |
| 50-Day Moving Average | 30.68 |
| 200-Day Moving Average | 30.69 |
| Relative Strength Index (RSI) | 57.48 |
| Average Volume (20 Days) | 176,363 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:1734 had revenue of TWD 3.35 billion and earned 345.57 million in profits. Earnings per share was 1.81.
| Revenue | 3.35B |
| Gross Profit | 1.43B |
| Operating Income | 411.00M |
| Pretax Income | 399.22M |
| Net Income | 345.57M |
| EBITDA | 652.98M |
| EBIT | 411.00M |
| Earnings Per Share (EPS) | 1.81 |
Balance Sheet
The company has 1.00 billion in cash and 1.67 billion in debt, with a net cash position of -670.03 million or -3.52 per share.
| Cash & Cash Equivalents | 1.00B |
| Total Debt | 1.67B |
| Net Cash | -670.03M |
| Net Cash Per Share | -3.52 |
| Equity (Book Value) | 3.57B |
| Book Value Per Share | 17.39 |
| Working Capital | 1.39B |
Cash Flow
In the last 12 months, operating cash flow was 572.20 million and capital expenditures -172.38 million, giving a free cash flow of 399.82 million.
| Operating Cash Flow | 572.20M |
| Capital Expenditures | -172.38M |
| Free Cash Flow | 399.82M |
| FCF Per Share | 2.10 |
Margins
Gross margin is 42.60%, with operating and profit margins of 12.28% and 10.33%.
| Gross Margin | 42.60% |
| Operating Margin | 12.28% |
| Pretax Margin | 11.93% |
| Profit Margin | 10.33% |
| EBITDA Margin | 19.52% |
| EBIT Margin | 12.28% |
| FCF Margin | 11.95% |
Dividends & Yields
This stock pays an annual dividend of 0.95, which amounts to a dividend yield of 3.08%.
| Dividend Per Share | 0.95 |
| Dividend Yield | 3.08% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 100.95% |
| Buyback Yield | -0.07% |
| Shareholder Yield | 3.02% |
| Earnings Yield | 5.88% |
| FCF Yield | 6.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 2, 2025. It was a forward split with a ratio of 1.05.
| Last Split Date | Sep 2, 2025 |
| Split Type | Forward |
| Split Ratio | 1.05 |
Scores
TPE:1734 has an Altman Z-Score of 2.52 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.52 |
| Piotroski F-Score | 7 |